Subscribe To
MBOT / Why Microbot Medical Shares Are Sliding Today
MBOT News
By GlobeNewsWire
September 8, 2023
Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
The presentation follows successful extensive uses of the Company's endovascular robotic system in pre-clinical studies The presentation follows succe more_horizontal
By InvestorPlace
May 23, 2023
3 Undervalued Penny Stocks to Buy for Multi-Bagger Returns
The stock market can provide investors with an unpredictable and thrilling journey, filled with both excitement and anticipation. This article will de more_horizontal
By MarketBeat
May 23, 2023
Microbot Medical spikes 150% on its Endovascular Surgical Robot
Microbot Medical Inc. NASDAQ: MBOT stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its more_horizontal
By PennyStocks
May 23, 2023
How to Handle Penny Stocks Volatility in 2023
Penny stocks continue to offer incredible opportunities for investors in 2023. As high-growth, micro-cap equities, they have the potential to outperfo more_horizontal
By Benzinga
December 28, 2021
Why Microbot Medical Shares Are Sliding Today
Microbot Medical Inc (NASDAQ: MBOT) is trading lower Tuesday as the stock pulls back following Monday's strength. Microbot Medical shares surged Mond more_horizontal
By Benzinga
December 28, 2021
Why Microbot Medical Shares Are Sliding Today
Microbot Medical Inc (NASDAQ: MBOT) is trading lower Tuesday as the stock pulls back following Monday's strength. Microbot Medical shares surged Mond more_horizontal
By Benzinga
December 28, 2021
Why Microbot Medical Shares Are Sliding Today
Microbot Medical Inc (NASDAQ: MBOT) is trading lower Tuesday as the stock pulls back following Monday's strength. Microbot Medical shares surged Mond more_horizontal
By GlobeNewsWire
October 6, 2021
Microbot Medical Secures Patent for LIBERTY® Robotic System in the United States
HINGHAM, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPT more_horizontal